elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42642023-6AB3028C-AE85-44BF-BC56-997BD4FD978E
Q42642023-6AB3028C-AE85-44BF-BC56-997BD4FD978E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42642023-6AB3028C-AE85-44BF-BC56-997BD4FD978E
Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma.
P2860
Q42642023-6AB3028C-AE85-44BF-BC56-997BD4FD978E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42642023-6AB3028C-AE85-44BF-BC56-997BD4FD978E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
60bbe5ec222bd1a8402d165839d708b8eb361283
P2860
Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma.